Hebei Changshan Biochemical Pharmaceutical Co., Ltd. announced that at its EGM held on December 30, 2021, shareholders approved the appointment of Liu Yanbin and Sun Yunxia as non-independent directors, Cao Deying and Wang Xiabngjun as independent directors and Gao Shuxuan and Wang Jinliang as non-employee supervisors.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
9.53 CNY | -3.35% |
|
-5.08% | -26.75% |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-26.75% | 1.25B | |
+2.88% | 93.97B | |
+6.58% | 41.61B | |
-13.20% | 33.32B | |
+77.12% | 28.8B | |
-16.02% | 15.61B | |
-8.17% | 13.27B | |
-12.49% | 11.46B | |
+162.44% | 10.06B | |
-54.92% | 9.09B |
- Stock Market
- Equities
- 300255 Stock
- News Hebei Changshan Biochemical Pharmaceutical Co., Ltd.
- Hebei Changshan Biochemical Pharmaceutical Co., Ltd. Announces Board Appointments